Health & Medicine

Muir, an assistant professor in the Department of Family and Community Health at Penn Nursing and emergency medicine at Penn Medicine, and a senior fellow in the Center for Health Outcomes and Policy Research and in the Leonard Davis Institute of Health Economics, has won the 2025 Nurse Researcher Award from the Emergency Nurses Association. The award honors individuals who have significantly contributed to the field of emergency nursing through research, dissemination of findings, and/or utilization of research to improve patient outcomes.

New research from Penn Nursing provides insight on the critical factors that help or hinder hospital nurses in delivering quality care to socially disadvantaged patients.

Corporate director of sustainability for the University of Pennsylvania Health System Greg Evans discusses steering Penn Medicine towards a greener future.

Penn Vet and Penn Medicine researchers have modified mRNA vaccines to include the cytokine IL-12 and improve T-cell responses which could improve the body’s ability to fight infections.

Coker, an associate professor in the Department of Basic and Translational Sciences at Penn Dental Medicine, is among 100 fellows from across the country selected for the 2025-2026 Hedwig van Ameringen Executive Leadership in Academic Medicine® (ELAM) program. Hosted by Drexel University College of Medicine, ELAM is dedicated to preparing women for senior leadership roles in schools of medicine, dentistry, public health and pharmacy.

At Penn Medicine, clinical trials are testing methods that may stop cancer from recurring.

A new study from Penn’s School of Veterinary Medicine on germ cell gene regulatory networks offers a holistic understanding of complex male germ cell differentiation in meiosis and spermatogenesis.

Daniel Zhang co-founded the Penn Medicine Symphony Orchestra in 2016 and served as its founding conductor. When moved into residency training, his brother David stepped up; he is the orchestra’s current music director and conductor.

Researchers from Penn Medicine have demonstrated encouraging tumor reductions rarely seen in recurrent glioblastoma following phase I clinical trials.

New research from Penn Medicine finds that ECT sets in motion a brain event that resets its neurons, and has the potential to guide personalized ECT dosing to target specific outcomes in the brain.